First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

BACKGROUND: In metastatic renal-cell carcinoma (mRCC), recent data have shown efficacy of first-line ipilimumab and nivolumab (ipi-nivo) as well as immuno-oncology (IO)/vascular endothelial growth factor (VEGF) inhibitor combinations. Comparative data between these strategies are limited. OBJECTIVE:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur Urol
Hauptverfasser: Dudani, Shaan, Graham, Jeffrey, Wells, J. Connor, Bakouny, Ziad, Pal, Sumanta K., Dizman, Nazli, Donskov, Frede, Porta, Camillo, de Velasco, Guillermo, Hansen, Aaron, Iafolla, Marco, Beuselinck, Benoit, Vaishampayan, Ulka N., Wood, Lori A., Liow, Elizabeth, Yan, Flora, Yuasa, Takeshi, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Y.C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858928/
https://ncbi.nlm.nih.gov/pubmed/31445844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.07.048
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge